Nebulized enriched heparin improves respiratory parameters in patients with COVID-19: a phase I/II randomized and triple-blind clinical trial.

Autor: Ramos da Silva Grillo, Vinicius Tadeu1 (AUTHOR), Bertanha, Matheus1,2 (AUTHOR) matheusbertanha@gmail.com, da Silva Rodrigues, Lenize1,2 (AUTHOR), de Lima, Marcelo Andrade3 (AUTHOR), Mellucci Filho, Pedro Luciano1 (AUTHOR), Rahal Guaragna Machado, Rafael4 (AUTHOR), Durigon, Edson Luiz4,5 (AUTHOR), Dias Sertorio, Nathália1 (AUTHOR), de Assis Golim, Marjorie2 (AUTHOR), Moroz, Andrei6 (AUTHOR), Marques Braz, Aline Márcia2 (AUTHOR), de Moraes, Leonardo Nazário2 (AUTHOR), Leite, Marco Antonio7 (AUTHOR), Bonciani Nader, Helena8 (AUTHOR), de Campos, Gustavo Constantino9 (AUTHOR), Rodrigues Guzzo Carvalho, Cristiane4 (AUTHOR), Florença Cardoso, Fábio10 (AUTHOR), Magro, Angelo José10 (AUTHOR), Caputo Nunes, Helga11 (AUTHOR), Tommasini Grotto, Rejane Maria2,12 (AUTHOR)
Zdroj: Scientific Reports. 8/27/2024, Vol. 14 Issue 1, p1-12. 12p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje